Skip to main content
CLRI
OTC Technology

Cleartronic Reports Q2 Profitability and Significant Deficit Reduction Amidst Strong Revenue Growth

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
7
Price
$0.011
Mkt Cap
$2.59M
52W Low
$0.001
52W High
$0.065
Market data snapshot near publication time

summarizeSummary

Cleartronic, Inc. reported a return to profitability for Q2 and the six months ended March 31, 2026, with strong revenue growth and a significant reduction in its accumulated deficit, though it noted ineffective internal controls and substantial potential dilution from preferred stock.


check_boxKey Events

  • Return to Profitability

    The company reported a net income of $53,652 for the three months ended March 31, 2026, and $238,115 for the six months, a significant improvement from net losses of $(38,210) and $(97,678) in the comparable prior-year periods.

  • Strong Revenue Growth

    Revenue increased by 18.60% to $1,133,502 for the quarter and 24.08% to $2,386,041 for the six months ended March 31, 2026, driven by growth in its ReadyOp and Alastar platforms and hardware sales.

  • Significant Reduction in Accumulated Deficit

    The accumulated deficit decreased substantially from $(356,650) as of September 30, 2025, to $(98,073) as of March 31, 2026, indicating a notable improvement in the company's equity position.

  • Material Weakness in Internal Controls

    Management concluded that the company's disclosure controls and procedures were not effective as of March 31, 2026, due to a limited number of personnel, posing a compliance risk.


auto_awesomeAnalysis

Cleartronic, a micro-cap company, achieved net income for the quarter and six-month period, a significant turnaround from losses in the prior year. This financial improvement, coupled with a substantial reduction in its accumulated deficit, indicates a positive shift in the company's operational health. However, the disclosure of ineffective internal controls and a massive potential dilution from convertible preferred stock present considerable risks that investors should carefully consider.

At the time of this filing, CLRI was trading at $0.01 on OTC in the Technology sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $0.00 to $0.07. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLRI - Latest Insights

CLRI
May 12, 2026, 1:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
CLRI
Feb 13, 2026, 2:55 PM EST
Filing Type: 10-Q
Importance Score:
8